Pharmacological Analysis Demonstrates Dramatic Alteration of D<sub>1</sub>Dopamine Receptor Neuronal Distribution in the Rat Analog of l-DOPA-Induced Dyskinesia
Amandine Berthet(Institut des Maladies Neurodégénératives), Bertrand Bloch(Victor (Japan)), Erwan Bézard(Centre National de la Recherche Scientifique), Martine Cador(Victor (Japan)), Holger Stark(Goethe University Frankfurt), Évelyne Doudnikoff(Victor (Japan)), Grégory Porras(Victor (Japan))
Cited by 135
Related Papers
International Union of Basic and Clinical Pharmacology. XCVIII. Histamine Receptors
|Pharmacological Reviews|2015|558
Targeting α-synuclein for treatment of Parkinson's disease: mechanistic and therapeutic considerations
|The Lancet Neurology|2015|508
Polypharmacology by Design: A Medicinal Chemist’s Perspective on Multitargeting Compounds
|Journal of Medicinal Chemistry|2018|476
Pathophysiology of L-dopa-induced motor and non-motor complications in Parkinson's disease
|Progress in Neurobiology|2015|472
Priorities in Parkinson's disease research
|Nature Reviews Drug Discovery|2011|430